Spectrumceuticals SporeBiotic
Indications: Spectrumceuticals SporeBiotic
- Maintain/support bowel regularity
- Decrease/reduce/relieve bowel discomfort in healthy adults
- Maintain/support healthy bowel/colon function
- Maintain/support general health and wellbeing
Active Ingredients: Spectrumceuticals SporeBiotic
Each vegetarian hard capsule contains: | |
Saccharomyces cerevisiae (boulardii) strain CNCM I-3799 | 250mg |
Bacillus coagulans MTCC 5260 | 2 Billion CFU |
Fructo-oligosaccharides | 100mg |
Bacillus coagulans Unique IS-2® has been completely characterized by phenotypic and genotypic (Whole Genome Sequencing) methods. Its probiotic properties have also been established and it has been deposited under Patent deposits at:
- American Type Culture Collection (ATCC) – assigned number ATCC PTA-11748
- Microbial Type Culture Collection (MTCC) and Gene Bank with an accession number of B. coagulans Unique IS-2® (MTCC 5260)
Excipients: Spectrumceuticals SporeBiotic
Excipient ingredients: microcrystalline cellulose, colloidal anhydrous silica, magnesium stearate, maltodextrin (maize starch) and size 0 hypromellose capsules.
Allergen Advice: Spectrumceuticals SporeBiotic
No added yeast, gluten, wheat, dairy, preservatives or artificial colours and flavours. Suitable for vegans.
Dose & Administration: Spectrumceuticals SporeBiotic
Adults: take 1 – 2 capsules daily, with water, or as directed by your healthcare professional.
If symptoms persist consult your healthcare practitioner.
Warnings: Spectrumceuticals SporeBiotic
Not suitable for children.
Bacillus coagulans may affect the way some medicines work, including immunosuppressants.
Consult your healthcare practitioner before taking other medicines.
Drink plenty of water.
Do not use when abdominal pain, nausea or vomiting are present, or if you develop diarrhoea. If you are pregnant or breastfeeding, seek the advice of a healthcare professional before taking this product.
Storage: Spectrumceuticals SporeBiotic
Store below 25 degrees Celsius away from direct sunlight.
Education: Spectrumceuticals SporeBiotic
Purpose
A comprehensive gastrointestinal formula designed to support bowel regularity, gut health and function. With robust soil based probiotic and yeast strains this product is shelf stable and has high potential for GI survivability and viability.
Formula contains a prebiotic (fructo-oligosaccharides), spore-based probiotic (Bacillus coagulans), and a probiotic yeast (Saccharomyces boulardii).
Bacillus coagulans
Bacillus coagulans form a spore, a temporary structure enveloped by a resistant outer coating. The spore germinates in the intestine, which is favourable for reactivation. The vegetative form of Bacillus coagulans is transient, the bacterium does not inhabit the intestine permanently.
- Soil-based bacterial species
- Spore-forming
- Gram-positive bacillus
- Non-pathogenic
- Facultative anaerobic
- Lactic acid-producing (produces L+ lactic acid only)
Benefits of Bacillus coagulans
- Shelf-stable and does not require refrigeration
- Maintains viability during preparation, manufacturing and storage until consumption
- Resistant to high temperatures
- Resistant to bile acids and acidic conditions of the stomach
- Spore-forming probiotics have a transient time of about three to four weeks, while traditional probiotics normally have a transient time of four to seven days. B.
- Coagulans were detected in a rat 28 days after consumption.
- Reported as GRAS (Generally Recognised as Safe)
- Resistant to antibiotics
Mechanism of action of Bacillus coagulans
Modulate the gut microbiota
B coagulans Unique IS-2 was able to modulate the gut microbiota by increasing beneficial bacteria. It has been shown to enhance bacterial genera:
- Lactobacillus
- Bifidobacterium
- Faecalibacterium
- Bacteroides
- Megamonas
- Lachnospira
- Blautia and
- Alistipes
Bacterial genera Lactobacillus, Bifidobacterium, and Faecalibacterium have been reported to be protective for mucosal inflammation in the host via several mechanisms, including the up-regulation of the anti-inflammatory cytokine, and down-regulation of inflammatory cytokines.
Populating the gut with beneficial bacteria restricts the growth of harmful microbes competing for nutrients and environment in the gut.
B. coagulans is capable of restoring microbial imbalance by generating an acidic environment that is harmful to many pathogenic microbes by fermenting polysaccharides.
Anti-inflammatory properties of Bacillus coagulans
- Increases the secretion of IL-10.
Alleviates digestive discomforts
- B. coagulans Unique IS2 significantly reduces abdominal pain and increases the number of complete spontaneous bowel movements (CSBM) in IBS patients. Symptoms such as bloating, incomplete evacuation, urgency, straining, passage of gas, bowel habit satisfaction, and stool consistency all improve after taking B. coagulans.
Shown efficacy in the treatment of:
- Constipation: Madempudi, R. S. et al. Bacillus coagulans Unique IS2 in constipation: a double-blind, placebo-controlled study. Probiotics Antimicrob. Proteins, https://doi.org/10.1007/s12602-019-09542-9 (2019)
- Diarrhoea: Sudha M. R., Radkar N. & Maurya, A. Effect of supplementation of probiotic Bacillus coagulans Unique IS-2 (ATCC PAT-11748) on hypercholesterolemic subjects: a clinical study. Int. J. Probiotics Prebiotics 6, 89–93 (2011).)
- Bacterial vaginosis: Sudha, R. M., Yelikar, K. A. & Deshpande, S. Clinical study of Bacillus coagulans Unique IS-2 (ATCC PTA-11748) in the treatment of patients with bacterial vaginosis. Indian J. Microbiol. 52, 396–399 (2012))
- IBS in adults and children: Sudha, M. R. et al. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study. Benef. Microbes 9, 563–572 (2018)
- Abdominal pain: Saneian, H. et al. Synbiotic containing Bacillus coagulans and fructo-oligosaccharides for functional abdominal pain in children. Gastro Hepatol. Bed Bench 8, 56–65 (2015)
- Hypercholesteremia: Sudha M. R., Radkar N. & Maurya, A. Effect of supplementation of probiotic Bacillus coagulans Unique IS-2 (ATCC PAT-11748) on hypercholesterolemic subjects: a clinical study. Int. J. Probiotics Prebiotics 6, 89–93 (2011)
- Liver cirrhosis (Pawar, R. R., Pardeshi, M. L. & Ghongane, B. B. Study of effects of probiotic lactobacilli in preventing major complications in patients of liver cirrhosis. Int. J. Res. Pharma. Biomed. Sci. 3, 206–211 (2012)
- Inflammatory Bowel Disorders: Bamola VD, Dubey D, Samanta P, et al. Effect of Bacillus coagulans Unique IS-2 in Inflammatory Bowel Disease (IBD): A Randomized Controlled Trial. medRxiv; 2021. DOI: 10.1101/2021.07.18.21260556.
Caution:
- Some experts are critical of spore-forming probiotics as these bacteria can be opportunistic, especially in people who are immunocompromised. If the microbiome isn’t strong, introducing resilient strains, may prove problematic
Saccharomyces boulardii (SB)
Non-pathogenic, non-colonising (transient) and shelf-stable probiotic yeast
Offers protection against pathogenic microorganisms and promotes the healing of the intestinal lining.
To consider several types of diarrhea, dyspepsia, recurrent Clostridium difficile-associated diseases, restoration of bowel function and flora, adjunctive treatment for H. pylori therapy, IBS and Crohn’s disease.
- Antibiotic resistant
- Anti-diarrheal, reducing; severity, duration and frequency of diarrhea
LUMINAL
Antitoxin
- Clostridium difficile (preventing disease recurrences)
- Cholera (Vibrio cholerae)
- E. coli
Selective Antibacterial
- Preserve tight epithelial cell junctions
- Selective bacterial adherence with SB = ↓ pathogenic invasion
- Antagonistic to C. albicans filamentation, adherence and biofilm formation
Modulate gut flora profile
- No unwanted effect on healthy gut flora in human controls
Re-establishment of short chain fatty acids (SCFAs),
- Supporting colon function,
- Reduce over fermentation in the bowel
- Increase recolonization of normal microbiota = Increase strengthened microbial barrier
MUCOSAL ANTI-INFLAMMATORY & IMMUNE MODULATION
- Reduce pro-inflammatory cytokines
- Increase Secretory IgA and IgG = Increase gut immune defence
Fructooligosaccharides (FOS)
Oligosaccharides are composed of linear chains of fructose units, linked by β (2-1) bonds.
FOS transits through the large bowel, is unabsorbed and is hydrolyzed into sugar. These sugars are fermented to short-chain fatty acids (SCFA). SCFA are absorbed by the colon and are the major respiratory fuels for colonocytes, supplying up to 60 to 70% of their energy needs. Acetate and lactate are the main SCFA produced by FOS.
SCFAs are known for their favourable modulatory effects on:
- Immune function
- gastrointestinal epithelial cell integrity
- glucose homeostasis
- lipid metabolism
- regulation of appetite
Prebiotic effects
FOS selectively promotes the growth and activity of specific spp of bacteria in the gut
In the colon, FOS specifically promote the growth of Bifidobacterium and Lactobacillus, which in turn produce enzymes that metabolise FOS
The beneficial bacterium discourages the growth of harmful bacteria such as C. difficile and E. coli.
Gastrointestinal effects
FOS increases defecation frequency and reduces bowel transit time in humans. As a prebiotic fibre, FOS promotes colonic fermentation leading to increased faecal biomass.
Summary of Actives, Needs and Benefits
Actives | Needs | Benefits |
Bacillus coagulans Saccharomyces Boulardii FOS |
Patients with generalised gut disorders. E.g. diagnosed IBS, poor overall gut health, bloating, flatulence, diarrhea, constipation, abdominal pain Patients with poor immune function |
Therapeutic efficacy for many gut disorders, improved patient signs and symptoms Reduced symptoms associated with Inflammatory Bowel Disease and Irritable bowel Syndrome. |
Bacillus coagulans | Patients with gastroenteritis and diarrhea (e.g. rotavirus) |
Prevention and treatment of diarrhoea. Competitive inhibition of pathogenic microorganisms in the gastrointestinal tract* |
FOS | Patients with poor gut microbial profile | Enhanced gut microbiota profile at therapeutic and safe adult dosing. Promotes the growth of the beneficial bacteria in the colon. |
Saccharomyces cerevisiae (boulardii) 500mg DBVPG isolate (10 billion CFU) |
Antibiotic associated diarrhea, traveller’s diarrhea (viral or parasitic) Chronic diarrhea, HIV related or when the origin is unknown * Blastocystis hominis Clostridium difficile, IBS, Crohn’s disease, giardiasis * E. coli overgrowth *, recurrent UTIs H. pylori infection. Triple therapy dyspepsia and epigastric distress |
Reduced severity and duration of diarrhea (all types) *. Potent, convenient dose for the patient. Protective effect on healthy gut flora *, promotion of secretory IgA Reduced E. coli overgrowth * Increased H. pylori eradication rate Reduced GIT distress during triple therapy Inhibited growth of Candida albicans and Salmonella enterica |
FAQ: Spectrumceuticals SporeBiotic
Is Saccharomyces cerevisiae (boulardii) CNCM I-3799 a probiotic?
A probiotic is a living microorganism (yeast or bacteria) that when taken in adequate amounts, confers a health benefit. Saccharomyces cerevisiae (boulardii) is therefore a probiotic by definition.
How do I store Saccharomyces cerevisiae (boulardii) fridge free probiotics, are they stable?
For fridge-free, shelf-stable probiotics, please store in a cool dry place below 25°C, or refrigerate if you like. Prolonged excessive moisture and high heat will accelerate probiotic deterioration. High temperatures can kill probiotics, and exposure to temperatures above 46°C can increase the rate of loss rapidly.
Do you have allergen and certification for the CNCM I-3799?
The ingredient is gluten-free, dairy free, non-GMO verified, Halal and Kosher.
We add no fillers or binders to this ingredient, only encapsulation in a hypromellose capsule suitable for vegans and vegetarians.
How do I store Bacillus coagulans Unique IS-2 fridge free probiotics, are they stable?
For fridge-free, shelf-stable probiotics, please store in a cool dry place below 25°C, or refrigerate if you like. Prolonged excessive moisture and high heat will accelerate probiotic deterioration. High temperatures can kill probiotics, and exposure to temperatures above 46°C can increase the rate of loss rapidly.